$3.01
0.196.74%
Matinas BioPharma Holdings Inc
MTNBAMEX
Matinas BioPharma Hldgs (MTNB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-3.15 | $-4.50 | $-3.90 | $-6.00 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Apr 15, 2025 | $-25.20 | $-11.70 | -115.4 % |
| Q3 | Nov 13, 2024 | $-12.75 | $-15.00 | 15.0 % |
| Q2 | Aug 14, 2024 | $-15.00 | $-15.00 | 0.00 % |
| Q1 | May 9, 2024 | $-22.50 | $-22.50 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 10, 2023 | $1.10M | $300.00K | 265.3 % |
| Q4 | Mar 15, 2023 | $1.06M | $1.10M | -3.36 % |
| Q3 | Nov 2, 2022 | $0 | $830.00K | -100.0 % |
| Q2 | Aug 11, 2022 | $1.06M | $100.00K | 963.0 % |
